Compare Apollo Global Management Ord Shs (APO) vs Moderna, Inc. (MRNA) Price & Performance

Apollo Global Management Ord ShsTrade

Moderna, Inc.Trade

Price performance (Past 24H)

Key statistics

Apollo Global Management Ord Shs vs Moderna, Inc. — how do they compare? Apollo Global Management Ord Shs trades at $140.98 (market cap $82.84B), while Moderna, Inc. trades at $60.5 (market cap $24.18B). The key difference: Apollo Global Management Ord Shs is far larger — about 3.4× Moderna, Inc.'s market cap, and Apollo Global Management Ord Shs pays a 1.6% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.

	APO	MRNA
Market Cap	$82.84B	$24.18B
Sector	Financials	Health
52-Week High	$152.70	$81.80
52-Week Low	$100.30	$22.36
Enterprise Value	-$168.65B	$20.33B
Dividend Yield	1.6%	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

APO

Nvidia leads $500B Wall Street consortium to finance AI infrastructure expansion.24/7 Wall Street · 1 day agoBullish Monogram Capital closes continuation vehicle for Mountaintop, funding expansion and returning capital to investors.PRNewsWire · 1 day agoBullish Wall Street giants plan $500B to finance AI infrastructure as a new asset class, says Nvidia CEO.CNBC · 1 day agoBullish View details →

MRNA

View details →

About Apollo Global Management Ord Shs

Apollo Global Management Inc is an alternative investment manager. It serves various sectors such as chemicals, manufacturing and industrial, natural resources, consumer and retail, consumer services, business services, financial services, leisure, and media and telecom and technology. The company operates in three business segments that are Private Equity, Credit, and Real Assets. It generates maximum revenue from the Credit segment in the form of fees. The credit segment primarily invests in non-control corporate and structured debt instruments including performing, stressed and distressed instruments across the capital structure. It also includes Corporate Credit

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.